An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
Guanethidine has been studied across 22 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🫘 Kidney, 🌤️ Mood & Depression, 💊 Pain. The primary research focus is ❤️ Cardiovascular with 35% of studies addressing this area.
The following compounds share molecular targets with Guanethidine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Guanethidine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.